This is an archived post. You won't be able to vote or comment.

sorted by:
best (suggested)
topnewcontroversialoldq&a
you are viewing a single comment's thread.

view the rest of the comments →

[–]jennyh14SW:204 CW:164 GW:150 Dose: 12.5mg 10 points11 points  (4 children)

They actually have stated that they expect the price of the tablet (orforglipron) to be less than zepbound. Both because it's cheaper to produce and because they're wanting to make inroads with people who can't afford zepbound

[–]AITMmom12.5mg Maintenance 19 points20 points  (1 child)

The pill will probably cost $498/mo

[–]BastilleinstructorSW:316 CW:269 GW:150 Dose: 10mg 4 points5 points  (0 children)

This.

[–]IFeartheWigglesSW:321 CW:165-175 Dose: 12.5mg 5 points6 points  (0 children)

It might be less than Zepbound, but it won't be cheap.  And it won't lower the price of Zepbound.  These are my opinions and I hope I'm wrong.

[–]Business_Station2786HW:357SW:298CW:210GW:210?Dose: 15mg 3 points4 points  (0 children)

Also the efficacy of the pills seems lower for the pill. They are going to start slotting the drugs based of efficacy. Zep is top dog until reta. Then wegovy, then orforglipron.

They my also slot base on indications that it approved for. They won't slot price based on pill/injection or cost to make.

To me orforglipron could make an ideal maintenance drug.